Detalhe da pesquisa
1.
An N6-methyladenosine regulation- and mRNAsi-related prognostic index reveals the distinct immune microenvironment and immunotherapy responses in lower-grade glioma.
BMC Bioinformatics
; 24(1): 225, 2023 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37264314
2.
CRB2 enhances malignancy of glioblastoma via activation of the NF-κB pathway.
Exp Cell Res
; 414(1): 113077, 2022 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35219647
3.
Retinol binding protein 1-dependent activation of NF- κB signaling enhances the malignancy of non-glioblastomatous diffuse gliomas.
Cancer Sci
; 113(2): 517-528, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34866280
4.
FABP5 enhances malignancies of lower-grade gliomas via canonical activation of NF-κB signaling.
J Cell Mol Med
; 25(9): 4487-4500, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33837625
5.
circKIF4A promotes tumorogenesis of glioma by targeting miR-139-3p to activate Wnt5a signaling.
Mol Med
; 26(1): 29, 2020 04 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32268875
6.
Serine/Threonine Kinase CHEK1-Dependent Transcriptional Regulation of RAD54L Promotes Proliferation and Radio Resistance in Glioblastoma.
Transl Oncol
; 11(1): 140-146, 2018 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-29287241
7.
Betulinic acid derivative B10 inhibits glioma cell proliferation through suppression of SIRT1, acetylation of FOXO3a and upregulation of Bim/PUMA.
Biomed Pharmacother
; 92: 347-355, 2017 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-28554130